ESR1-Driven Resistance to CDK4/6 Inhibitors in Breast Cancer Thwarted by SERDs
(MedPage Today) -- Mutations in ESR1 do not appear to confer breast cancer resistance to cyclin-dependent kinase (CDK)4/6 inhibitors, an analysis of clinical practice data suggested.
Patients with metastatic hormone receptor-positive breast cancer... (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - April 25, 2024 Category: OBGYN Source Type: news
AI Model Reduces False Positives in Screening Mammograms
THURSDAY, April 25, 2024 -- A semiautonomous breast cancer screening system reduces false positives with screening mammograms, according to a study published online April 10 in Radiology: Artificial Intelligence.
Stefano Pedemonte, Ph.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 25, 2024 Category: Pharmaceuticals Source Type: news
A commentary on "Breast-conserving surgery is associated with a lower incidence of suicide among females with breast cancer in the United States: a population-based retrospective cohort study" - Brice ño-Morales C, Briceño-Morales X.
[Abstract unavailable]
Language: en... (Source: SafetyLit)
Source: SafetyLit - April 25, 2024 Category: International Medicine & Public Health Tags: Research Methods, Surveillance and Codes, Models Source Type: news
Xcision to feature GammaPod - a powerful tool for breast cancer - at ESTRO 2024
Xcision Medical Systems, LLC, a medical technology company that develops advanced stereotactic radiotherapy solutions to improve cancer care, will demonstrate GammaPod® at The European Society for Radiotherapy and Oncology (ESTRO) on May 3-7 in Glasgow, United Kingdom. COLUMBIA, Md.,... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 25, 2024 Category: Pharmaceuticals Tags: PDT FVT Source Type: news
Breast Cancer Survivors Face Higher Odds for Second Cancer
THURSDAY, April 25, 2024 -- People lucky enough to survive a breast cancer may still face heightened risks for other cancers later, a new study shows.
The researchers stressed that the absolute risk of a secondary cancer to any one survivor is... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 25, 2024 Category: General Medicine Source Type: news
Studies lacking for trans breast cancer screening trends
There are limited studies that examine breast cancer screening trends in transgender people, according to a report published April 23 in the Journal of the American College of Radiology.
A team led by Millie Chokshi from the University of Miami in Florida found that while studies that do include transgender participants have mixed results, these participants had lower rates of breast cancer screening than cisgender participants.
“More research is needed regarding breast cancer screening of transgender and gender-diverse people to inform the development of protocols that ensure equitable access to preventative care,”...
Source: AuntMinnie.com Headlines - April 25, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Womens Imaging Breast Imaging Source Type: news
Deprivation linked to higher second cancer risk among England breast cancer survivors
Cambridge study finds those from poorest areas have 35% higher risk of second non-breast cancerFemale survivors of breast cancer living in the most deprived areas have a 35% higher risk of developing second, unrelated cancers, compared with those from the most affluent areas,research shows.Breast cancer is the most commonly diagnosed cancer in the UK, with about 56,000 people being told they have it each year. Improved diagnosis and treatments mean thatfive-year survival rates are now 86% in England.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - April 24, 2024 Category: Science Authors: Anna Bawden Health and social affairs correspondent Tags: Cancer Health Society Breast cancer Women's health Inequality Social exclusion England Medical research Science University of Cambridge UK news NHS Source Type: news
Mortality Up for Breast Cancer Diagnosed Within 10 Years of Childbirth
WEDNESDAY, April 24, 2024 -- Young-onset breast cancer (YOBC) with germline BRCA pathogenic variants (PVs) is associated with an increased risk for all-cause mortality if diagnosed within 10 years after childbirth, according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 24, 2024 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19
Group sales grew by 2%1 at constant exchange rates (CER) (-6% in CHF), driven by the strong growth of newer medicines and diagnostics. Excluding COVID-19-related products, sales increased by 7%. Going forward, there will be no further material impact of COVID-19 sales declineDue to the appreciation of the Swiss franc against most currencies,saleswere 6% lower when reported in CHFPharmaceuticals Divisionbase business2 grew by 7%, driven by strong sales of medicines to treat severe diseases, such as Vabysmo (eye diseases), Phesgo (breast cancer), Ocrevus (multiple sclerosis), Polivy (blood cancer) and Hemlibra (haemophilia A...
Source: Roche Investor Update - April 24, 2024 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19
Group sales grew by 2%1 at constant exchange rates (CER) (-6% in CHF), driven by the strong growth of newer medicines and diagnostics. Excluding COVID-19-related products, sales increased by 7%. Going forward, there will be no further material impact of COVID-19 sales declineDue to the appreciation of the Swiss franc against most currencies,saleswere 6% lower when reported in CHFPharmaceuticals Divisionbase business2 grew by 7%, driven by strong sales of medicines to treat severe diseases, such as Vabysmo (eye diseases), Phesgo (breast cancer), Ocrevus (multiple sclerosis), Polivy (blood cancer) and Hemlibra (haemophilia A...
Source: Roche Media News - April 24, 2024 Category: Pharmaceuticals Source Type: news
Honoring Audrey Beverly Christy Mastroianni at United Breast Cancer Foundation's Mattress and Pink Bag Event: "Gifts of Comfort and Hope" in Warwick, Rhode Island
Breast Cancer Patient and Survivor Pampering Event this Saturday, April 27, 2024 at Warwick Mall WARWICK, R.I., April 23, 2024 /PRNewswire-PRWeb/ -- United Breast Cancer Foundation (UBCF) is proud to host a heartfelt event dedicated to honor the memory of Audrey Beverly Christy... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 24, 2024 Category: Pharmaceuticals Tags: CSR FVT NPT Source Type: news
Beyond2020 highlights AI-powered mammography services in Costa Rica
Beyond2020, an initiative launched by the Zayed Sustainability Prize, is highlighting the deployment of AI-powered mammography services across Costa Rica to support women living in underprivileged communities.
The prize is the United Arab Emirates' award for sustainability and humanitarianism. The initiative aims to improve access to high-quality healthcare for women in the region. A total of 8,000 tests will be conducted annually using the AI-based mammography services, which have been deployed in Juan Pablo II Medical Centre in Cartago, with plans to deploy the services in additional health facilities in the future.A te...
Source: AuntMinnie.com Headlines - April 23, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
Higher Dietary Quality at Breast Cancer Diagnosis Linked to Lower CVD Risk
TUESDAY, April 23, 2024 -- Higher diet quality at diagnosis of breast cancer is associated with a lower risk for cardiovascular disease (CVD) events and death, especially the Dietary Approaches to Stop Hypertension diet quality index, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 23, 2024 Category: Pharmaceuticals Source Type: news
Relationship With Partner Affects Outcomes for Breast Cancer Survivors
MONDAY, April 22, 2024 -- A strong relationship can help a breast cancer survivor thrive in the aftermath of their terrible ordeal, a new study finds.Diagnosis and treatment of breast cancer places tremendous stress on the women and their partners,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 22, 2024 Category: General Medicine Source Type: news
Mobile health screening model lowers costs, promotes sustainability
A new cancer screening service model developed by Italian researchers can reduce direct non-medical costs and improve environmental sustainability for breast cancer screening and other screening exams.
The investigators, led by doctoral candidate Vera Benedetto from the Health Science Interdisciplinary Center in Pisa, found that their model, which utilizes mobile cancer screening for breast, cervical, and colorectal cancer, reduced costs by over 95,000 euros ($101,155 U.S.) in terms of travel costs and productivity losses. It also reduced as much as 35 tons of carbon dioxide (CO2)-equivalent travel emissions for a popula...
Source: AuntMinnie.com Headlines - April 22, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Practice Management Source Type: news
